- Filed
- Mar 21, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 1, 2025 | 54.71M sh |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $38.55M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $18.4M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $28.94M |
| Current Assets | FY 2024 · Dec 31, 2023 | $229.23M |
| Total Assets | FY 2024 · Dec 31, 2023 | $257.39M |
| Shares Diluted restated | FY 2024 · Dec 31, 2022 | 43.46M sh |
| Capex | FY 2024 · Dec 31, 2022 | $7.44M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | −$109.91M |
| Eps Diluted restated | FY 2024 · Dec 31, 2022 | −$3.39 |
| Eps Basic restated | FY 2024 · Dec 31, 2022 | −$3.39 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $31.07M |
| Rd Expense | FY 2024 · Dec 31, 2022 | $109.59M |
| Net Income | FY 2024 · Dec 31, 2022 | −$147.31M |
| Operating Income | FY 2024 · Dec 31, 2022 | −$151.96M |
| Gross Profit | FY 2024 · Dec 31, 2022 | −$4.26M |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $8.45M |
| Revenue | FY 2024 · Dec 31, 2022 | $4.19M |
| Stockholders Equity restated | FY 2024 · Dec 31, 2021 | $456.38M |